Nanjing Gaoke CoSHSE:600064 +0.96%59 EBITDA Margin % is 110.84% as of Mar. 2026, which is 86% above its 10-year median of 59.48. GuruFocus rates SHSE:600064 with a GF Score™ of 59/100 and a GF Value™ of ¥7.73 (Fairly Valued). The stock has 9 warning signs investors should review. Among 1,745 Real Estate companies, Nanjing Gaoke Co ranks better than 77.59% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nanjing Gaoke Co's EBITDA for the
three
months ended in Mar. 2026 was ¥673 Mil. Nanjing Gaoke Co's Revenue for the
three
months ended in Mar. 2026 was ¥607 Mil. Therefore, Nanjing Gaoke Co's EBITDA margin for the quarter that ended in Mar. 2026 was 110.84%.
Nanjing Gaoke Co (SHSE:600064) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Nanjing Gaoke Co EBITDA Margin % Related Terms
Nanjing Gaoke Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Nanjing Gaoke Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Gaoke Co EBITDA Margin % Competitor Comparison
For the Real Estate - Development subindustry, Nanjing Gaoke Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanjing Gaoke Co EBITDA Margin % vs Real Estate Industry
For the Real Estate industry and Real Estate sector, Nanjing Gaoke Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Nanjing Gaoke Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Gaoke Co (SHSE:600064) has a EBITDA Margin % of 110.84% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nanjing Gaoke Co and its competitors. This is 86% above median its historical median of 59.48. Over the past decade, Nanjing Gaoke Co's EBITDA Margin % has ranged from 27.39 to 91.76. According to the industry distribution chart, Nanjing Gaoke Co ranks #391 out of 1745 companies in the Real Estate industry, placing it in the top 22.4%.
Is Nanjing Gaoke Co's EBITDA Margin % too high?
Nanjing Gaoke Co's current EBITDA Margin % of 110.84% is 86% above median its 10-year median of 59.48. Over the past 10 years, this metric has ranged from a low of 27.39 to a high of 91.76. The Real Estate industry median EBITDA Margin % is 21.62. Nanjing Gaoke Co's value of 110.84% is 412.7% above this industry median. Based on the distribution chart, Nanjing Gaoke Co ranks #391 out of 1745 companies in the Real Estate industry, which is in the top quartile — a strong position relative to peers. Overall, Nanjing Gaoke Co has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Gaoke Co's EBITDA Margin % compare to competitors?
According to the Real Estate industry distribution chart, Nanjing Gaoke Co ranks #391 out of 1745 companies for EBITDA Margin %. This places Nanjing Gaoke Co in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 21.62. Nanjing Gaoke Co's value of 110.84% is 412.7% above this benchmark. Historically, Nanjing Gaoke Co's own EBITDA Margin % has ranged from 27.39 to 91.76 over the past decade. While the company's 10-year median is 59.48 vs. the industry median of 21.62, Nanjing Gaoke Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Real Estate company?
The median EBITDA Margin % among Real Estate companies is 21.62, based on 1,745 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanjing Gaoke Co's current EBITDA Margin % of 110.84% is 412.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nanjing Gaoke Co and its competitors. For the Real Estate industry, the median EBITDA Margin % is 21.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanjing Gaoke Co's current EBITDA Margin % is 110.84%, which is 86% above median its own 10-year median of 59.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Gaoke Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Gaoke Co (SHSE:600064) is currently considered Fairly Valued. The stock's GF Value™ is ¥7.73, compared to a current price of ¥7.34 — trading 5% below its estimated fair value. The current EBITDA Margin % is 110.84%, which is 86% above median its 10-year median of 59.48 and 412.7% above the Real Estate industry median of 21.62. Nanjing Gaoke Co's overall GF Score™ is 59/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nanjing Gaoke Co (SHSE:600064), the current EBITDA Margin % is 110.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanjing Gaoke Co (SHSE:600064) Overvalued in 2026?
Based on GuruFocus' analysis, Nanjing Gaoke Co stock appears to be undervalued.
The current stock price of ¥7.34 is trading 5% below its estimated GF Value™ of ¥7.73.
GuruFocus considers Nanjing Gaoke Co to be Fairly Valued.
Key valuation signals for SHSE:600064:
EBITDA Margin %: 110.84% (86% above median its 10-year median of 59.48)
GF Value™: ¥7.73 vs. price of ¥7.34 (5% below fair value)
Industry Position: 412.7% above the Real Estate median (#391 of 1745)
No single metric tells the full story. See the SHSE:600064 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanjing Gaoke Co Ltd is a China-based company engaged in real estate and municipal businesses, medical health business, and equity investment business. Its real estate business includes residential development, commercial operations, and property management, among others. Its medical health business includes the research and development, manufacture and sales of pharmaceuticals.
59GF Score
Get the complete analysis for SHSE:600064
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600064 has been successfully added to your 
